Evidence map›Paper›PMID 34359384›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer.

Jim Zhong, Ebrahim Palkhi, David L Buckley, Fiona J Collinson, Christy Ralph, Satinder Jagdev, Naveen S Vasudev, Jayne Swain, Janet E Brown, Tze Min Wah

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jim ZhongDepartment of Diagnostic and Interventional Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK.
Ebrahim PalkhiDepartment of Diagnostic and Interventional Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK.
David L BuckleyBiomedical Imaging, School of Medicine, University of Leeds, Leeds LS2 9JT, UK.ORCID 0000-0001-6659-8365
Fiona J CollinsonDepartment of Medical Oncology, St James's Institute of Oncology, Leeds LS9 7TF, UK.
Christy RalphDepartment of Medical Oncology, St James's Institute of Oncology, Leeds LS9 7TF, UK.
Satinder JagdevDepartment of Medical Oncology, St James's Institute of Oncology, Leeds LS9 7TF, UK.
Naveen S VasudevDepartment of Medical Oncology, St James's Institute of Oncology, Leeds LS9 7TF, UK.
Jayne SwainClinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds LS9 7TF, UK.
Janet E BrownDepartment of Medical Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, UK.
Tze Min WahDepartment of Diagnostic and Interventional Radiology, Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK.ORCID 0000-0001-5670-5454
St James's University Hospital · GBLeeds Teaching Hospitals NHS Trust · GBUniversity of Leeds · GBUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-angiogenic therapydynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)metastatic renal cell cancertyrosine kinase inhibitor

Identifiers

PMID34359384
PMCPMC8306403
OpenAlexW3184616252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.